GlassScriptPhysician profile
Amy L Wardell
NPI 1952360166
$3,316.65
in general payments reported to CMS, 2019-2025
19 companies · $481 in 2025
The $481 reported for 2025 was more than what 76% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $269 · 2021: $759 · 2022: $491 · 2023: $397 · 2024: $443 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,320.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,449.16 | 2019-2025 | Precision 1, Tryptyr, Rocklatan |
| Sun Pharmaceutical Industries INC. | $309.07 | 2019-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $283.33 | 2019-2023 | |
| Allergan, INC. | $214.57 | 2019-2021 | |
| Oyster Point Pharma, INC. | $151.92 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $118.41 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $111.93 | 2020-2022 | |
| Biotissue Holdings INC. | $109.82 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $102.36 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Coopervision INC. | $102.09 | 2019-2024 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.94 | 2019-2021 | |
| Dompe US, INC. | $56.46 | 2024-2025 | Oxervate |
| Sight Sciences, INC. | $50.38 | 2021-2022 | |
| Abbvie INC. | $46.44 | 2022-2023 | Durysta |
| Thea Pharma INC. | $39.37 | 2023-2025 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $35.66 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $26.10 | 2019-2020 | |
| Lkc Technologies, INC. | $22.99 | 2025 | |
| Eyevance Pharmaceuticals LLC | $15.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wardell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.